Neighborhood Social Vulnerability and Access to Expedited Partner Therapy Prescriptions: A Secret Shopper Audit Survey
- 13 October 2025
- journal article
- Published by Wolters Kluwer Health in Sexually Transmitted Diseases
- Vol. 53 (2) , 67-74
Abstract
Background: Sexually transmitted infections (STIs) disproportionately affect socially vulnerable populations. Expedited partner therapy (EPT) reduces reinfection rates by treating partners without requiring a medical visit yet remains underutilized in the electronic prescription era. Studies show low pharmacist awareness of EPT, with limited research on its real-world availability in pharmacies or variability by Social Vulnerability Index (SVI) factors. This study assessed pharmacist awareness and willingness to fill hypothetical nameless electronic EPT prescriptions in New York City pharmacies and examined variations by SVI. Methods: A cross-sectional audit survey of 335 New York City pharmacies used a telephone-based secret shopper approach. Pharmacist awareness of EPT, willingness to fill, and insurance acceptance were evaluated. Multivariable logistic regression examined associations with SVI, adjusting for pharmacy type, location, and local chlamydia rates. Results: Of surveyed pharmacies, 40% were aware of EPT, with significantly lower awareness in nonchain pharmacies than national chains (34% vs. 54%, P = 0.02). Only 28% of pharmacists stated they would be willing to fill nameless prescriptions. Most prescriptions (34%) would be filled under the index patient's name, and 86% would accept insurance. Common reasons for refusal included unfamiliarity with EPT (62%) and misconceptions about legal name requirements (28%). Awareness was higher in pharmacies located in the highest SVI quartile (odds ratio, 3.7; 95% confidence interval, 1.3–10.8), but willingness to fill did not vary by SVI ( P = 0.35). Conclusions: Despite greater EPT awareness in socioeconomically vulnerable areas, pharmacist willingness to fill nameless EPT prescriptions remains limited across areas. Efforts to educate pharmacists and standardize e-prescribing processes are needed to expand EPT access and reduce STI disparities.Keywords
This publication has 17 references indexed in Scilit:
- The Importance of Structural Interventions for Advancing Sexual Health and Health Equity in the United States: A Review of the Evidence and Recommendations for Action on Sexually Transmitted InfectionsSexually Transmitted Diseases, 2022
- County-Level Chlamydia and Gonorrhea Rates by Social Vulnerability, United States, 2014–2018Sexually Transmitted Diseases, 2022
- State-Level Social Vulnerability Index and Healthcare Access: The Behavioral Risk Factor Surveillance System SurveyAmerican Journal of Preventive Medicine, 2022
- The Estimated Direct Lifetime Medical Costs of Sexually Transmitted Infections Acquired in the United States in 2018Sexually Transmitted Diseases, 2021
- County-level Social Vulnerability is Associated With Worse Surgical Outcomes Especially Among Minority PatientsAnnals of Surgery, 2020
- Breakdown in the expedited partner therapy treatment cascade: from reproductive healthcare provider to the pharmacistAmerican Journal of Obstetrics and Gynecology, 2020
- Naloxone Availability and Pharmacy Staff Knowledge of Standing Order for Naloxone in Pennsylvania PharmaciesJournal of Addiction Medicine, 2019
- Social Vulnerability in Congenital Syphilis Case Mothers: Qualitative Assessment of Cases in Indiana, 2014 to 2016Sexually Transmitted Diseases, 2018
- Expedited Partner Therapy: Pharmacist Refusal of Legal PrescriptionsSexually Transmitted Diseases, 2018
- Explaining disparities in HIV infection among black and white men who have sex with men: a meta-analysis of HIV risk behaviorsAIDS, 2007